Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Nanoscale Delivery Systems For MicroRNAs In Cancer Therapy

Sanda C Boca, Diana Gulei, Alina-Andreea Zimta, Anca Onaciu, Lorand Magdo, A. B. Țigu, C. Ionescu, A. Irimie, R. Buiga, I. Berindan-Neagoe
Published 2019 · Computer Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Concomitant with advances in research regarding the role of miRNAs in sustaining carcinogenesis, major concerns about their delivery options for anticancer therapies have been raised. The answer to this problem may come from the world of nanoparticles such as liposomes, exosomes, polymers, dendrimers, mesoporous silica nanoparticles, quantum dots and metal-based nanoparticles which have been proved as versatile and valuable vehicles for many biomolecules including miRNAs. In another train of thoughts, the general scheme of miRNA modulation consists in inhibition of oncomiRNA expression and restoration of tumor suppressor ones. The codelivery of two miRNAs or miRNAs in combination with chemotherapeutics or small molecules was also proposed. The present review presents the latest advancements in miRNA delivery based on nanoparticle-related strategies.
This paper references
10.1038/ncomms12868
Local microRNA delivery targets Palladin and prevents metastatic breast cancer
A. Gilam (2016)
10.1007/978-981-10-0818-4_3
Metallic Nanoparticles, Toxicity Issues and Applications in Medicine
R. Singla (2016)
10.1021/acsami.8b07698
Stimuli-Responsive Nanocarrier for Co-delivery of MiR-31 and Doxorubicin To Suppress High MtEF4 Cancer.
F. Wang (2018)
10.1038/nrd3179
Targeting microRNAs in cancer: rationale, strategies and challenges
R. Garzon (2010)
10.1007/978-3-319-89878-0_3
Quantum Dots for Cancer Therapy and Bioimaging
F. Wu (2018)
10.1186/s12951-018-0368-8
Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection
V. Chaudhary (2018)
10.1093/NAR/GKH516
2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
B. H. Yoo (2004)
10.1016/j.drudis.2018.04.003
Design strategies for physical-stimuli-responsive programmable nanotherapeutics.
F. F. Sahle (2018)
10.2147/IJN.S158290
Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
Y. Li (2018)
10.1002/cam4.1016
MiR‐101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma
F. Xu (2017)
Imag - ing and inhibition of multi - drug resistance in cancer cells via specific association with negatively charged CdTe quantum dots
Y Zhou
10.1038/srep24436
Lymphatic transport of exosomes as a rapid route of information dissemination to the lymph node
S. Srinivasan (2016)
10.1088/0957-4484/26/5/055101
Comparative toxicity evaluation of flower-shaped and spherical gold nanoparticles on human endothelial cells.
Sadequa Sultana (2015)
10.1016/j.bios.2018.03.022
Simultaneous detection of gastric cancer-involved miR-106a and let-7a through a dual-signal-marked electrochemical nanobiosensor.
M. Daneshpour (2018)
10.18632/ONCOTARGET.3046
Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma
L. Cai (2015)
10.1073/pnas.1201516109
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
Imran Babar (2012)
10.1007/s11095-008-9766-1
Development of a Novel Method for Formulating Stable siRNA-Loaded Lipid Particles for In vivo Use
S. Wu (2008)
10.1016/j.tibtech.2011.06.009
Molecular aptamers for drug delivery.
Weihong Tan (2011)
10.1038/nnano.2012.73
Molecularly Self-Assembled Nucleic Acid Nanoparticles for Targeted In Vivo siRNA Delivery
Hyukjin Lee (2012)
10.1002/anie.201500628
Visible-Light-Activated Molecular Switches.
D. Bléger (2015)
10.1016/j.biomaterials.2010.02.053
Imaging and inhibition of multi-drug resistance in cancer cells via specific association with negatively charged CdTe quantum dots.
Y. Zhou (2010)
Yadav S. Toxicity issues and applications in medicine
R Singla (2016)
10.1098/rstb.2013.0502
Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers
M. Li (2014)
10.2147/DDDT.S142337
The new era of nanotechnology, an alternative to change cancer treatment
Ancuța Jurj (2017)
10.4155/tde-2016-0060
Recent advances in light-responsive on-demand drug-delivery systems.
Chase S Linsley (2017)
10.2174/1381612820666140826153529
NCRNA combined therapy as future treatment option for cancer.
C. Braicu (2014)
10.1021/MA0106346
Poly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA Delivery
D. Luo (2002)
10.1016/j.jconrel.2013.10.023
The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice.
H. Hatakeyama (2013)
Randall Lee T . Enhanced magnetic and optical properties for emerging biological applications , Bimet Nanoparticles
P Srinoi
10.2147/IJN.S12125
Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method
Z. Urbán-Morlán (2010)
10.1093/nar/gkq727
Structural basis of microRNA length variety
Julia Starega-Roslan (2011)
10.1155/2012/936041
Polymeric and Ceramic Nanoparticles in Biomedical Applications
A. Moreno-Vega (2012)
10.1038/nbt.3330
Principles of nanoparticle design for overcoming biological barriers to drug delivery
E. Blanco (2015)
10.1021/acs.accounts.5b00270
Red-Shifting Azobenzene Photoswitches for in Vivo Use.
Ming-xin Dong (2015)
Self-assembled dual fluorescence nanoparticles for CD44targeted delivery of anti-miR-27a in liver cancer theranostics. Theranostics
X Zheng (2018)
BerindanNeagoe I (2018) Exosomes-small players big sound
D Gulei (2018)
10.2147/IJN.S79598
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
Wendian Zhang (2015)
The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice.
H. Hatakeyama (2014)
10.1007/s10637-016-0407-y
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
M. S. Beg (2016)
10.1016/j.addr.2014.05.009
In vivo delivery of miRNAs for cancer therapy: challenges and strategies.
Yunching Chen (2015)
10.3390/cancers9070071
Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications
L. Sempere (2017)
10.2144/04374te01
DNA nanotechnology.
Seunghyun Lee (2004)
10.1002/advs.201700542
In Situ Monitoring of MicroRNA Replacement Efficacy and Accurate Imaging‐Guided Cancer Therapy through Light‐Up Inter‐Polyelectrolyte Nanocomplexes
Xiongwei Deng (2018)
10.1016/j.nano.2015.10.011
Chitosan polyplex mediated delivery of miRNA-124 reduces activation of microglial cells in vitro and in rat models of spinal cord injury.
A. M. Louw (2016)
10.1016/j.jconrel.2014.02.019
Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499.
H. Ando (2014)
10.1039/B517710C
Cationic phosphorus-carbon-pnictogen cages isolobal to [C5R5]+.
C. Fish (2006)
10.1016/j.apsb.2016.02.001
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
Dinh Ha (2016)
10.1021/acs.chemrev.5b00346
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.
Nazila Kamaly (2016)
10.3390/cells7120265
Liposomal Delivery of miR-34b-5p Induced Cancer Cell Death in Thyroid Carcinoma
Hamidreza Maroof (2018)
10.1007/s00280-013-2361-0
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
A. W. Tolcher (2013)
10.1007/s00396-015-3550-7
Zwitterionic light-responsive polymeric micelles for controlled drug delivery
Hanjian Shen (2015)
Antitumor efficiency of lipid-coated cisplatin nanoparticles co-loaded with MicroRNA-375. Theranostics
T Yang (2016)
Lipidbased nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma
L Piao (2012)
Aptamers and their biological applications . Sensors
KM Song (2012)
Berindan-Neagoe I (2013) p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells
C Braicu
10.3390/polym9040152
Stimuli-Regulated Smart Polymeric Systems for Gene Therapy
Ansuja Pulickal Mathew (2017)
10.1039/B200777K
Photoremovable protecting groups: reaction mechanisms and applications.
A. P. Pelliccioli (2002)
10.1007/s10439-015-1331-6
Effect of Varying Magnetic Fields on Targeted Gene Delivery of Nucleic Acid-Based Molecules
O. Oral (2015)
10.1021/acsami.7b05145
Antibody Conjugated, Raman Tagged Hollow Gold-Silver Nanospheres for Specific Targeting and Multimodal Dark-Field/SERS/Two Photon-FLIM Imaging of CD19(+) B Lymphoblasts.
T. Nagy-Simon (2017)
10.1016/j.jconrel.2016.04.005
Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs.
S. Stremersch (2016)
10.2147/IJN.S41782
Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer
Hung-Yen Lee (2013)
10.1093/NAR/30.10.E45
High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands.
A. Tahiri-Alaoui (2002)
10.1038/sj.gt.3301624
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
Friedrich Scherer (2002)
10.1021/acs.langmuir.8b01831
Quantification of Loading and Laser-Assisted Release of RNA from Single Gold Nanoparticles.
C. Florentsen (2018)
10.1016/j.ijpharm.2010.04.027
Dendrimer toxicity: Let's meet the challenge.
K. Jain (2010)
10.1248/BPB.32.706
N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex.
Qing-Qing Zhao (2009)
10.1007/s11605-016-3222-z
Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy
Saini Setua (2016)
10.1039/C3MD00314K
Pre-miRNA expressing plasmid delivery for anti-cancer therapy
Elena Benisvy-Aharonovich (2014)
10.1021/mp400300m
Folic acid-conjugated, SERS-labeled silver nanotriangles for multimodal detection and targeted photothermal treatment on human ovarian cancer cells.
Sanda Boca-Farcau (2014)
A phase 1 study of the BCL2targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
AW Tolcher (2014)
10.1111/cas.13267
Co‐delivery of microRNA‐21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy
Y. Li (2017)
10.1016/J.BIOMATERIALS.2007.04.004
Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
Payal Agrawal (2007)
10.4172/1948-593X.1000049
Nobel Metallic Nanoparticles with Novel Biomedical Properties
F. S. Rosarin (2011)
10.1039/c5nr06122a
Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery.
S. Heidegger (2016)
10.1038/nmat4497
Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment.
J. Conde (2016)
10.1002/adma.201601646
Porous Silicon and Polymer Nanocomposites for Delivery of Peptide Nucleic Acids as Anti-MicroRNA Therapies.
Kelsey R. Beavers (2016)
10.1021/LA036154K
A nonviral transfection approach in vitro: the design of a gold nanoparticle vector joint with microelectromechanical systems.
C. Jen (2004)
10.1016/j.nano.2009.07.002
Biological synthesis of metallic nanoparticles.
Kaushik N. Thakkar (2010)
10.1021/MA201924H
o-Nitrobenzyl Alcohol Derivatives: Opportunities in Polymer and Materials Science
H Zhao (2012)
Quantification of loading and laserassisted release of RNA from single gold nanoparticles. Langmuir
C D Florentsen (2018)
10.1007/s40820-017-0166-0
A Concise Review of Gold Nanoparticles-Based Photo-Responsive Liposomes for Controlled Drug Delivery
Malathi Mathiyazhakan (2018)
10.1016/j.colsurfb.2012.06.026
Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
Zhuo Guo (2013)
10.1002/btm2.10034
Nanoengineered thermoresponsive magnetic hydrogels for biomedical applications
Nima A. Jalili (2016)
10.1016/B978-0-12-416020-0.00007-3
Polymer nanoparticles.
Xiaoyun Lu (2011)
10.1038/nmat3776
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
10.1155/2011/469031
Bacterial Magnetosome: A Novel Biogenetic Magnetic Targeted Drug Carrier with Potential Multifunctions.
Jianbo Sun (2011)
Poly(ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA Deliv
D Luo (2002)
10.1158/1078-0432.CCR-16-1025
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
Katrien Van Roosbroeck (2016)
10.1073/PNAS.97.10.5633
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.
C. Wahlestedt (2000)
10.1088/0957-4484/22/5/055702
Flower-shaped gold nanoparticles: synthesis, characterization and their application as SERS-active tags inside living cells.
Sanda C Boca (2011)
10.1155/2013/209452
Magnetofection: A Reproducible Method for Gene Delivery to Melanoma Cells
L. Prosen (2013)
lung cancer cells
KR Beavers (2016)
How do Manufactured Nanoparticles Enter Cells
J. Rappoport (2011)
10.1016/J.ADDR.2005.09.019
Dendrimer biocompatibility and toxicity.
R. Duncan (2005)
10.1021/acsnano.7b07538
Modulation of Angiogenic Activity by Light-Activatable miRNA-Loaded Nanocarriers.
Miguel M Lino (2018)
Evaluation of mesoporous TCPSi, MCM-41, SBA15, and TUD-1 materials as API carriers for oral drug delivery. Drug Delivery
T Heikkila (2007)
10.1007/s41061-017-0119-6
Stimuli-Responsive Polymeric Nanocarriers for Efficient Gene Delivery
Y. Li (2017)
Mesoporous silica nanoparticles for drug and gene delivery . Acta pharmaceutica Sinica B
Y Li (2018)
10.18632/oncotarget.5192
miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
K. O'Brien (2015)
10.1038/pr.2014.202
Adipocyte-derived Exosomal miRNAs: A Novel Mechanism for Obesity-Related Disease
S. Ferrante (2015)
10.1021/ACS.JPCC.6B02436
Spherical and Flower-Shaped Gold Nanoparticles Characterization by Scattering Correlation Spectroscopy
N. Djaker (2016)
10.1021/nn301714n
Cytotoxic effects of gold nanoparticles: a multiparametric study.
Stefaan J. Soenen (2012)
10.2217/nnm-2017-0353
Dual targeting delivery of miR-328 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy.
Y. Li (2018)
10.7508/ibj.2016.01.001
Toxicity of Nanoparticles and an Overview of Current Experimental Models
Haji Bahadar (2016)
10.4155/TDE.11.12
Nucleic acid delivery using magnetic nanoparticles: the Magnetofection technology.
Nicolas Laurentt (2011)
10.1371/journal.pone.0139136
Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells
H. Wang (2015)
10.1002/wrna.1229
MicroRNAs as therapeutic targets in human cancers
M. Shah (2014)
10.1039/B601776M
Enzyme-responsive materials: a new class of smart biomaterials
Rein V. Ulijn (2006)
10.1093/neuonc/nox152
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas
F. Lang (2018)
10.1002/anie.201300183
NIR-triggered anticancer drug delivery by upconverting nanoparticles with integrated azobenzene-modified mesoporous silica.
Jianan Liu (2013)
Yadav S . Toxicity issues and applications in medicine , Met Nanoparticles
B Petrushev (2016)
10.1166/JBN.2016.2274
Modulation of MicroRNAs 34a and 21 Affects Viability, Senescence, and Invasion in Glioblastoma Multiforme.
Y. Yin (2016)
10.1021/jacs.6b08369
Optimized DNA "Nanosuitcases" for Encapsulation and Conditional Release of siRNA.
Katherine E Bujold (2016)
10.4161/cbt.11.9.15185
Chitosan hydrogel for localized gene silencing
H. Han (2011)
10.1007/s13346-013-0160-0
Overcoming obstacles in microRNA delivery towards improved cancer therapy
D. Ben-Shushan (2013)
Multifunctional core-shell nanoplatforms
A Assali (2018)
Stimuliresponsive polymeric nanocarriers for efficient gene delivery
Y Li (2017)
10.1016/j.actbio.2017.12.028
Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
Yanan Kang (2018)
10.1088/0957-4484/21/23/235601
Detoxification of gold nanorods by conjugation with thiolated poly(ethylene glycol) and their assessment as SERS-active carriers of Raman tags.
Sanda C Boca (2010)
10.1038/ncomms10376
Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects
X. Zhang (2016)
10.2147/IJN.S94689
Microarc-oxidized titanium surfaces functionalized with microRNA-21-loaded chitosan/hyaluronic acid nanoparticles promote the osteogenic differentiation of human bone marrow mesenchymal stem cells
Z. Wang (2015)
10.18632/oncotarget.13431
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
Huiying Xue (2016)
10.1016/j.ijpharm.2016.05.027
Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Jianfeng Guo (2016)
10.1016/j.addr.2008.03.018
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
10.1021/acs.molpharmaceut.5b00878
Lipid Nanoparticles Composed of Quaternary Amine-Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer.
Bryant C Yung (2016)
10.2147/IJN.S198848
Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
N. Iturrioz-Rodríguez (2019)
10.1002/ADFM.201002373
Wavelength-Selective Light-Induced Release from Plasmon Resonant Liposomes.
Sarah Leung (2011)
10.1016/j.biotechadv.2017.11.003
Targeting ncRNAs by plant secondary metabolites: The ncRNAs game in the balance towards malignancy inhibition.
Diana Gulei (2018)
10.1016/j.toxlet.2012.11.022
Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts.
R. Coradeghini (2013)
10.1007/s00216-018-0859-3
Sensitive electrochemical detection of microRNA-21 based on propylamine-functionalized mesoporous silica with glucometer readout
Kun Deng (2018)
10.3390/antiox7010003
Natural Nanoparticles: A Particular Matter Inspired by Nature
S. Griffin (2017)
10.4155/fmc.14.116
miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.
V. Baumann (2014)
10.1021/acsami.8b09086
Overcoming Chemoresistance in Cancer via Combined MicroRNA Therapeutics with Anticancer Drugs Using Multifunctional Magnetic Core-Shell Nanoparticles.
P. T. Yin (2018)
Stimuliresponsive polymeric nanocarriers for efficient gene
Y Li (2017)
10.3760/CMA.J.ISSN.1673-4181.2003.01.009
DNA nanotechnology
傅占江 (2003)
Bioassay of azobenzene for possible carcinogenicity.
(1979)
10.1016/j.gpb.2015.02.001
Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
J. Zhang (2015)
10.1007/s00441-014-2087-2
Quantum dots for quantitative imaging: from single molecules to tissue
T. Q. Vu (2014)
10.2147/IJN.S36111
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
E. Fröhlich (2012)
10.4103/0975-7406.130965
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Kanika Madaan (2014)
10.1117/12.812186
Breast cancer targeting novel microRNA-nanoparticles for imaging
A. Natarajan (2009)
Using Magnetic Nanoformulation for Pancreatic Cancer Therapy
10.1016/S0378-5173(02)00623-3
The influence of surface modification on the cytotoxicity of PAMAM dendrimers.
R. Jevprasesphant (2003)
10.4161/hv.26796
Polymeric nanoparticles
A. Bolhassani (2014)
10.4155/tde.13.8
EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors.
T. Stylianopoulos (2013)
Toxicity issues and applications in medicine, Met Nanoparticles
R Singla (2016)
10.7860/JCDR/2016/18712.7922
Aptamers in Therapeutics.
Abhishek Parashar (2016)
10.1371/journal.pone.0062589
Multiple-to-Multiple Relationships between MicroRNAs and Target Genes in Gastric Cancer
Y. Hashimoto (2013)
10.3390/ijms18122620
A Looking-Glass of Non-Coding RNAs in Oral Cancer
A. Irimie (2017)
10.1002/chem.201405936
Light-triggered capture and release of DNA and proteins by host-guest binding and electrostatic interaction.
Johanna Moratz (2015)
10.1007/s11010-013-1688-5
p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells
C. Braicu (2013)
10.1038/srep03883
Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia
Y. Endo-Takahashi (2014)
10.3390/s120100612
Aptamers and Their Biological Applications
Kyung-Mi Song (2012)
10.1042/BST0390559
Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis.
Sanyukta Rana (2011)
10.2174/0929867311320290002
MicroRNAs and cancer therapy - from bystanders to major players.
C. Braicu (2013)
10.1002/adma.201503799
Near-Infrared-Triggered Azobenzene-Liposome/Upconversion Nanoparticle Hybrid Vesicles for Remotely Controlled Drug Delivery to Overcome Cancer Multidrug Resistance.
Chi Yao (2016)
10.2147/IJN.S94064
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
B. Petrushev (2016)
10.1016/j.nano.2014.09.014
Mesoporous silica nanoparticles in drug delivery and biomedical applications.
Y. Wang (2015)
10.1016/S0378-5173(03)00132-7
A PEGylated dendritic nanoparticulate carrier of fluorouracil.
D. Bhadra (2003)
10.1016/j.jconrel.2015.02.018
Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer.
T. Wang (2015)
10.1021/JA0380852
Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles.
S. Sun (2004)
10.1016/j.jconrel.2015.09.011
On-demand drug delivery from local depots.
Yevgeny Brudno (2015)
10.1016/j.jconrel.2014.08.015
Stimuli-responsive nanomaterials for therapeutic protein delivery.
Y. Lu (2014)
10.2147/NSA.S99986
Synthesis, characterization, applications, and challenges of iron oxide nanoparticles
Attarad Ali (2016)
10.1021/nl104329y
Electrically actuatable smart nanoporous membrane for pulsatile drug release.
G. Jeon (2011)
10.1371/journal.pone.0065540
Cellular Delivery of Quantum Dot-Bound Hybridization Probe for Detection of Intracellular Pre-MicroRNA Using Chitosan/Poly(γ-Glutamic Acid) Complex as a Carrier
Y. Geng (2013)
10.1002/jcb.24038
Non‐coding RNAs as theranostics in human cancers
Roxana S. Redis (2012)
10.1186/1479-5876-9-86
Body fluid derived exosomes as a novel template for clinical diagnostics
S. Keller (2011)
10.1021/am400374c
MicroRNA functionalized microporous titanium oxide surface by lyophilization with enhanced osteogenic activity.
Kaimin Wu (2013)
10.1038/mt.2012.67
Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma.
L. Piao (2012)
10.3389/fnmol.2016.00129
Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review
Ming Ming Wen (2016)
10.1038/mt.2012.180
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells.
Shin-ichiro Ohno (2013)
10.3390/nano7070189
Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer
Anna Watermann (2017)
10.1021/acs.biomac.5b00497
Shape Transformation of Light-Responsive Pyrene-Containing Micelles and Their Influence on Cytoviability.
H. Wang (2015)
10.1016/j.jconrel.2016.03.008
Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy.
Y. Ren (2016)
10.1093/nar/gkq1270
Unexpected origins of the enhanced pairing affinity of 2′-fluoro-modified RNA
P. Pallan (2011)
10.1039/c6cs00636a
Cellular uptake of nanoparticles: journey inside the cell.
Shahed Behzadi (2017)
Randall Lee T. Enhanced magnetic and optical properties for emerging biological applications
P Srinoi (2018)
10.1016/j.biomaterials.2014.01.060
Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs.
L. Zhu (2014)
10.1016/j.nano.2014.03.014
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.
F. Momen-Heravi (2014)
10.1002/smll.201101018
Nucleic acid-gold nanoparticle conjugates as mimics of microRNA.
Liangliang Hao (2011)
10.1039/c5cs00586h
Functional nucleic acid-based hydrogels for bioanalytical and biomedical applications.
Juan Li (2016)
10.3390/cancers10090289
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
Prashanth K B Nagesh (2018)
10.1021/ja908124g
Dual redox responsive assemblies formed from diselenide block copolymers.
N. Ma (2010)
10.1039/c6an02609e
Hemispherical platinum : silver core : shell nanoparticles for miRNA detection.
E. Spain (2017)
10.1021/acsnano.5b07846
ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects.
Daixin Ye (2016)
Imag - ing and inhibition of multi - drug resistance in cancer cells via specific association with negatively charged CdTe quantum dots
DX Ye
10.2147/IJN.S60488
Nanopharmacology in translational hematology and oncology
C. Tomuleasa (2014)
10.1021/nn503513p
Addressing the Instability of DNA Nanostructures in Tissue Culture
Jaeseung Hahn (2014)
10.1016/j.addr.2013.12.008
Liposomal siRNA nanocarriers for cancer therapy.
B. Ozpolat (2014)
10.1021/acsami.8b06642
Polyamino Acid Layer-by-Layer (LbL) Constructed Silica-Supported Mesoporous Titania Nanocarriers for Stimuli-Responsive Delivery of microRNA 708 and Paclitaxel for Combined Chemotherapy.
B. Gupta (2018)
10.1002/adhm.201601041
Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.
L. Wang (2017)
Codelivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy
Y Li (2017)
10.1016/j.omtn.2018.07.013
Combined Therapy in Cancer: The Non-coding Approach
Diana Gulei (2018)
10.1039/c2cc37556g
DNA nanostructure serum stability: greater than the sum of its parts.
J. W. Conway (2013)
10.1021/acs.bioconjchem.8b00003
Exosomes-Small Players, Big Sound.
Diana Gulei (2018)
Bottleneck limitations for microRNA-based therapeutics from bench to the bedside.
Y. Chen (2015)
10.1021/LA0624384
Density control of poly(ethylene glycol) layer to regulate cellular attachment.
T. Satomi (2007)
10.2147/IJN.S154458
Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells
G. Liang (2018)
10.1016/0968-0896(95)00171-9
Peptide nucleic acids (PNA): synthesis, properties and potential applications.
B. Hyrup (1996)
10.1039/c2cs35094g
Cationic polymers and their therapeutic potential.
S. K. Samal (2012)
10.1039/c4sm00871e
Photo-responsive polymeric micelles.
Y. Huang (2014)
10.1007/BF02668091
Specific targeting of folate–dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts
S. Konda (2007)
10.1021/acs.chemrev.5b00049
Toward Biocompatible Semiconductor Quantum Dots: From Biosynthesis and Bioconjugation to Biomedical Application.
J. Zhou (2015)
10.1016/j.jconrel.2017.07.047
Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
A. Maleki (2017)
10.1016/j.jconrel.2012.01.014
Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
G. Chiou (2012)
10.2147/IJN.S124584
Delivery of antagomiR204-conjugated gold nanoparticles from PLGA sheets and its implication in promoting osseointegration of titanium implant in type 2 diabetes mellitus
Xiangwei Liu (2017)
10.1039/C7PY01603D
Entry of nanoparticles into cells: the importance of nanoparticle properties
J. Zhao (2018)
10.3892/or.2013.2283
Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells.
X. Liu (2013)
10.1073/PNAS.95.8.4607
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.
S. Hobbs (1998)
10.1089/nat.2017.0716
Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs
L. Johannes (2018)
10.1039/B616746B
Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials.
R. Mellaerts (2007)
10.1016/j.cell.2004.12.035
Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets
B. P. Lewis (2005)
Molecular aptamers for drug
W Tan (2011)
10.7150/thno.13130
Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375
Tan Yang (2016)
10.3390/nano1010031
Functionalized Gold Nanoparticles and Their Biomedical Applications
P. Tiwari (2011)
10.3390/pharmaceutics6010001
Phototriggerable Liposomes: Current Research and Future Perspectives
A. Puri (2013)
10.1021/nl1040836
Stability of DNA origami nanoarrays in cell lysate.
Qian Mei (2011)
10.1016/j.apsb.2018.01.007
Mesoporous silica nanoparticles for drug and gene delivery
Yixian Zhou (2018)
10.1039/C5TB02191J
Magnetic field responsive drug release from magnetoliposomes in biological fluids.
S. Nappini (2016)
10.2147/IJN.S135306
Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma
H. Xue (2017)
10.1021/la502131h
Nonphospholipid fluid liposomes with switchable photocontrolled release.
Zhong-Kai Cui (2014)
10.1021/cr100449n
Core/shell nanoparticles: classes, properties, synthesis mechanisms, characterization, and applications.
Rajib Ghosh Chaudhuri (2012)
10.7150/thno.25255
Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics
X. Zheng (2018)
10.1016/j.jcis.2014.08.019
Modulating in vitro release and solubility of griseofulvin using functionalized mesoporous silica nanoparticles.
Siddharth Jambhrunkar (2014)
10.1016/j.biomaterials.2012.10.023
A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells.
Rajib Ghosh (2013)
10.1016/j.ejpb.2019.01.002
Polymeric nanoparticles for the delivery of miRNA to treat Chronic Obstructive Pulmonary Disease (COPD)
A. Mohamed (2019)
10.1038/nbt994
In vivo cancer targeting and imaging with semiconductor quantum dots
X. Gao (2004)
10.1093/NAR/GKG393
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.
Frank Czauderna (2003)
10.1021/nl304287a
Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery.
Shan Jiang (2013)
10.3390/molecules22091401
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Livia Palmerston Mendes (2017)
10.1016/j.ijpharm.2013.12.017
Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
D. Kumar (2014)
10.1021/nn203430m
Drug release from electric-field-responsive nanoparticles.
Jun Ge (2012)
10.1016/j.biomaterials.2009.03.016
Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent.
A. Agarwal (2009)
10.1016/J.IJPHARM.2005.01.026
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting.
D. Bhadra (2005)
10.1038/86684
A clearer vision for in vivo imaging
R. Weissleder (2001)
10.1021/ja304263n
DNA origami as a carrier for circumvention of drug resistance.
Q. Jiang (2012)
10.1126/science.1214081
A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads
S. Douglas (2012)
10.1016/j.ijpharm.2017.07.079
Enhanced efficacy of anti-miR-191 delivery through stearylamine liposome formulation for the treatment of breast cancer cells.
S. Sharma (2017)
10.1158/0008-5472.CAN-16-0359
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.
Alexander A. Svoronos (2016)
Dendrimer biocompatibility and toxic
R Duncan (2005)
10.1016/j.nano.2018.05.016
Multifunctional core-shell nanoplatforms (gold@graphene oxide) with mediated NIR thermal therapy to promote miRNA delivery.
Akram Assali (2018)
10.3892/or.2015.4524
MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
S. Xu (2016)
10.1146/annurev-biochem-060308-102244
Nanomaterials based on DNA.
N. Seeman (2010)
10.1186/2040-2384-2-14
Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability
H. Sarin (2010)
10.3892/ijmm.2018.3383
Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review)
J. Pan (2018)
10.1371/journal.pcbi.1000176
Differentiating Protein-Coding and Noncoding RNA: Challenges and Ambiguities
M. Dinger (2008)
10.1007/s10555-017-9714-9
MiR-181 family-specific behavior in different cancers: a meta-analysis view
Cecilia Pop-Bica (2017)
10.1016/j.ebiom.2016.09.017
microRNA Therapeutics in Cancer — An Emerging Concept
M. Shah (2016)
10.1016/J.MICROMESO.2016.08.014
Improved solubility of celecoxib by inclusion in SBA-15 mesoporous silica: Drug loading in different solvents and release
Z. Eren (2016)
10.1002/smll.201500540
Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells.
A. Bertucci (2015)
10.1039/C3TB20614A
Design, engineering and structural integrity of electro-responsive carbon nanotube- based hydrogels for pulsatile drug release.
A. Servant (2013)
10.1021/acs.analchem.7b05235
Strand Displacement Amplification Reaction on Quantum Dot-Encoded Silica Bead for Visual Detection of Multiplex MicroRNAs.
Xiaojun Qu (2018)
10.20944/PREPRINTS201804.0104.V1
Bimetallic Nanoparticles: Enhanced Magnetic and Optical Properties for Emerging Biological Applications
Pannaree Srinoi (2018)
10.1007/978-94-007-2555-3_13
Ultrasound activated nano-encapsulated targeted drug delivery and tumour cell poration.
D. Gourevich (2012)
10.1021/acsnano.5b08145
Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel.
Penghui Zhang (2016)
10.1021/acs.nanolett.8b00390
Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival.
H. Lopez-Bertoni (2018)
10.1080/10717540601098823
Evaluation of Mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 Materials as API Carriers for Oral Drug Delivery
T. Heikkilä (2007)
10.1186/1556-276X-9-247
Dendrimers: synthesis, applications, and properties
E. Abbasi (2014)
10.1016/j.ejmech.2008.06.012
PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist.
V. Gajbhiye (2009)
10.1038/nature04586
Folding DNA to create nanoscale shapes and patterns
P. Rothemund (2006)
10.18632/oncotarget.25135
Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model
M. Malhotra (2018)
10.1186/s13046-015-0216-8
Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted anti-tumor drug delivery system with sequential release functions
L. Fan (2015)
10.1080/14686996.2018.1528850
Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment
L. Li (2018)
10.1016/j.canlet.2017.09.043
Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
Congcong Xu (2018)
10.1186/s12951-016-0237-2
Targeted imaging and induction of apoptosis of drug-resistant hepatoma cells by miR-122-loaded graphene-InP nanocompounds
X. Zeng (2017)



This paper is referenced by
10.1038/s41416-020-01219-3
COVID-19 vaccine race: watch your step for cancer patients
R. Fanciullino (2020)
10.1016/j.semcancer.2019.12.004
Glyco-Nanoparticles: New drug delivery systems in cancer therapy.
H. Khan (2019)
10.1002/kjm2.12273
Inhibiting microRNA‐301b suppresses cell growth and targets RNF38 in cervical carcinoma
Wen-Ling Guo (2020)
10.1093/cvr/cvaa071
Non-coding RNA therapeutics for cardiac regeneration.
L. Braga (2020)
10.1016/j.coph.2020.08.004
MicroRNAs as mediators of drug resistance mechanisms.
A. Lampis (2020)
10.1016/j.exer.2020.108280
Prolonged use of nitric oxide donor sodium nitroprusside induces ocular hypertension in mice.
C. Hu (2020)
10.1186/s13287-020-01909-y
MicroRNA-27b targets CBFB to inhibit differentiation of human bone marrow mesenchymal stem cells into hypertrophic chondrocytes
S. Lv (2020)
10.7150/thno.25255
Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics
X. Zheng (2018)
10.1016/j.ijpharm.2020.119985
Testosterone-loaded GM1 micelles targeted to the intracellular androgen receptor for the specific induction of genomic androgen signaling.
N. Peinetti (2020)
10.3390/pharmaceutics12050402
Adipocyte-Based Cell Therapy in Oncology: The Role of Cancer-Associated Adipocytes and Their Reinterpretation as Delivery Platforms
R. Munteanu (2020)
10.1161/CIRCRESAHA.120.315855
Gene Therapy for the Heart Lessons Learned and Future Perspectives
A. Cannatà (2020)
10.1016/j.bbcan.2020.188481
Mechanisms of docetaxel resistance in prostate cancer: the key role played by miRNAs.
M. Rizzo (2020)
Semantic Scholar Logo Some data provided by SemanticScholar